SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-216576
Filing Date
2017-06-28
Accepted
2017-06-28 16:32:57
Documents
8
Period of Report
2017-06-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d442960d8k.htm 8-K 37918
2 EX-10.1 d442960dex101.htm EX-10.1 173025
3 EX-10.2 d442960dex102.htm EX-10.2 63283
4 EX-10.3 d442960dex103.htm EX-10.3 6221
5 EX-10.4 d442960dex104.htm EX-10.4 40203
6 EX-10.5 d442960dex105.htm EX-10.5 59039
7 EX-99.1 d442960dex991.htm EX-99.1 13201
8 GRAPHIC g442960g37e68.gif GRAPHIC 3658
  Complete submission text file 0001193125-17-216576.txt   399645
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 17935636
SIC: 2834 Pharmaceutical Preparations